Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 6,550.00
-30.00 (-0.46%)
At close: Jan 23, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 49.58 billion as of January 30, 2026. Its market cap has increased by 22.61% in one year.
Market Cap
49.58B
Enterprise Value
36.11B
Revenue
34.38B
Ranking
n/a
PE Ratio
7.51
Stock Price
6,550.00
Market Cap Chart
Since January 26, 2021, Wonbiogen's market cap has increased from 47.59B to 49.58B, an increase of 4.18%. That is a compound annual growth rate of 0.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 49.65B | 4.79% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG MedTech | 165.21B |
| T&R Biofab | 153.65B |
| OSTEONIC | 128.19B |
| JW Shinyak | 116.22B |
| Sewoon Medical | 102.82B |
| SCL Science | 78.41B |
| KM Corporation | 45.76B |
| MEDYSSEY Co.,Ltd | 39.65B |